Adherence to a Mediterranean lifestyle—incorporating specific dietary choices, regular physical activity, adequate rest, and robust social connections—is significantly associated with a lower risk of major adverse cardiovascular events and mortality among adults living with type 2 diabetes, according to a cohort analysis published in the journal eClinicalMedicine.
Cardiovascular Risk and the Type 2 Diabetes Landscape
Global projections indicate that type 2 diabetes prevalence will climb by 62% between 2021 and 2050, ultimately affecting upwards of 1.27 billion individuals worldwide. Within this clinical population, cardiovascular disease remains the primary driver of morbidity and mortality. Patients face up to a 2.5-fold higher risk of major adverse cardiovascular events, clinically referred to as MACE, which encompasses heart failure, ischemic stroke, myocardial infarction, revascularization procedures, and cardiovascular death.
While the health benefits of the traditional Mediterranean diet are well-documented for the general population, data examining comprehensive lifestyle metrics specifically within non-Mediterranean type 2 diabetes cohorts have remained scarce. To address this clinical evidence gap, researchers turned to the UK Biobank database to evaluate more than 3,600 adults diagnosed with type 2 diabetes.
In Plain English: The Clinical Takeaway
- MACE (Major Adverse Cardiovascular Events): A composite clinical endpoint that includes heart attacks, strokes, heart failure, and cardiovascular-related deaths.
- MEDLIFE Index: A validated 25-item scoring tool used to measure a person’s adherence to traditional Mediterranean habits, split across food intake, dietary behaviors, and social-physical routines.
- Ischemic Stroke & Myocardial Infarction: Medical terms for a stroke caused by a blocked blood vessel in the brain and a heart attack caused by blocked blood flow to the heart muscle, respectively.
Methodology and the Modified MEDLIFE Index
The study analyzed data from adults aged 40 to 70 years drawn from the United Kingdom Biobank cohort who had a confirmed type 2 diabetes diagnosis at baseline and had completed at least two dietary assessments. Researchers evaluated baseline diet adherence using repeated 24-hour dietary assessments collected via the Oxford WebQ questionnaire. Additional lifestyle metrics—including physical activity, sedentary time, social habits, and rest patterns—were gathered using touchscreen questionnaires.
To quantify lifestyle habits, investigators utilized the Mediterranean Lifestyle (MEDLIFE) index. This metric comprises 25 distinct items divided into three specific blocks: Mediterranean food intake, Mediterranean dietary habits, and conviviality, rest, physical activity, and social habits. Because certain components of the original index—such as olive oil consumption, sofrito intake, snacking habits outside of meals, and eating meals with company—were absent from the baseline UK Biobank questionnaires, the research team utilized a modified version of the MEDLIFE index.
The primary outcomes measured during the follow-up period included the incidence of MACE, cardiovascular mortality, and all-cause mortality. To isolate the impact of lifestyle choices, researchers calculated hazard ratios using Cox proportional hazard models. These models underwent rigorous successive adjustments. The primary analytic model, designated Model 4, accounted for core demographic variables, body mass index, smoking status, supplement use, total energy intake, cardiovascular medications, intermediate clinical conditions like hypertension, and specific type 2 diabetes prognostic factors such as age at diagnosis, disease duration, and baseline glycemic control.
| Parameter | Clinical Metric / Value |
|---|---|
| Total Study Cohort | 3,612 adults with type 2 diabetes |
| Age Range | 40 to 70 years (Mean age: 59.8 years) |
| Sex Distribution | Approximately 34% female |
| Mean MEDLIFE Score | 8.8 for females; 8.4 for males |
| Primary Endpoints Evaluated | MACE, cardiovascular mortality, all-cause mortality |
Insights from the Cohort Analysis
The analysis revealed that participants scoring in the highest quartile of the MEDLIFE index shared specific demographic and behavioral traits. These individuals were more likely to be female, older, non-smokers, and possess higher levels of educational attainment compared to participants in the lowest quartile. Out of the total cohort, 737 individuals experienced primary cardiovascular or mortality endpoints during the tracking period, allowing researchers to draw robust statistical correlations between higher lifestyle scores and improved clinical trajectories.
Secondary analyses within the investigation further parsed out the relative contributions of individual MEDLIFE blocks and explored associations with specific components of MACE. The findings underscore that a holistic approach integrating dietary patterns with physical activity, proper rest, and social connectivity offers measurable protection against vascular complications in patients managing chronic metabolic disease.
Clinical Trajectory and Future Public Health Impact
As the global prevalence of metabolic disorders continues to scale upward, identifying modifiable risk factors remains a central pillar of preventative cardiology. The findings from this UK Biobank analysis reinforce the clinical utility of comprehensive lifestyle interventions in mitigating vascular complications for vulnerable patient groups. Integrating validated tools like the MEDLIFE index into routine clinical counseling may offer physicians a structured framework to help patients reduce long-term cardiovascular risk.
